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Volume 69, no. 3, p. 1643–1649, 2001. Page 1644, column 1, lines 6 and 7 from the bottom: “. . .g representing diester linkages
and phosphorothioate linkages being to the right of lowercase letters” should read “. . . g representing a nuclease-resistant
phosphorothioate linkage on the right side of the base and the capital letters in the middle of the oligonucleotide sequences
representing phosphodiester linkages between the bases.”
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